Registration for the 2010 Call-on Congress Closes Feb. 1

Posted by Catherine Knowles on January 12th, 2010

March is quickly approaching, and now is the time to register for the 2010 Call-on Congress!

We already have a number of great speakers confirmed -

  • Public relations expert Caitlin Carroll will be leading a breakout session on media advocacy.
  • Dr. Jeffrey Chou will be speaking about the innovative research he has been doing with stem cells using a grant he received last year from C3′s Lisa Fund.
  • Author and CRC survivor Brenda Elsagher will be talking about her battle with cancer.
  • Donna Kimbark, PhD, PRCRP Program Manager, Congressionally Directed Medical Research Programs IPA of Battelle Memorial Institute will update attendees regarding colorectal cancer research in the Peer Reviewed Cancer Research Program and the Congressionally Directed Medical Research Programs.
  • Dr. Laura Seeff, Acting Chief, Comprehensive Cancer Control Branch, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention will be talking about the program’s recent expansion and what is in store for 2010.

Register today, to hear from these and lots of other great speakers!

Read the rest of this entry »

Tags: , Comments (1): Add a comment

C3 Helps Secure $15 Million for New Cancer Research Program

Posted by Catherine Knowles on December 16th, 2009

As a result of C3’s advocacy efforts, $15 million for a new peer reviewed cancer research program is included in the final Fiscal Year 2010 Defense Appropriations Bill.

The program will research cancers, like colorectal cancer, that are not addressed in the breast, prostate, lung and ovarian cancer research programs run by the U.S. Army Medical Research and Material Command (USAMRMC).  In addition to colorectal cancer research, the funds will be used to conduct research in the following areas: melanoma and other skin cancers, pediatric brain tumors within the field of childhood cancer research, genetic cancer research and genomic medicine, kidney cancer, blood cancer, Listeria Vaccine for infectious disease and cancer, and radiation protection utilizing nanotechnology.

The $15 million in funding for this new cancer research program was included at the request of Representatives Kay Granger (R-TX) and Jim Moran (D-VA).

Read the rest of this entry »

Prevent Cancer Foundation Celebrates 25 Years

Posted by Kate Murphy on December 16th, 2009
Carolyn "Bo" Aldige

Carolyn "Bo" Aldige

C3 congratulates the Prevent Cancer Foundation on their 25th anniversary this month.

We are proud of the work they do, especially in encouraging screening to prevent colorectal cancer.  This March they will sponsor the 12th Dialogue for Action Prevention Hits the Headlines.

Prevent Cancer also sponsors the Super Colon Tour, an educational program accompanied by a large crawl-through colon.  2010 tour appearances are being scheduled now. Read the rest of this entry »

Must Watch Thanksgiving TV

Posted by Kate Murphy on November 25th, 2009
Nancy Kerrigan

Nancy Kerrigan

After the football and the turkey, tune in Kaleidoscope on Thanksgiving.  C3 is part of the show!

Featuring cancer survivors Dorothy Hamill, Scott Hamilton, and Olivia Newton-John, Kaleidoscope focuses on women and cancer, raising awareness of how cancer affects women and providing strength to triumph over it.

Taped before an audience almost entirely of cancer survivors, Kaleidoscope will air at 4 p.m. EST, Thursday, November 26, Thanksgiving Day on FOX.

Watch for the more than 200 C3 cancer survivors and their families who were at the taping in the Verizon Center. Read the rest of this entry »

Tags: , Comments (0): Add a comment

Conference on Clinical Cancer Research: Meeting Report

Posted by Nancy Roach on October 7th, 2009

Nancy Roach is the Founder of C3 and Chair of the Board of Directors.

On September 14, I participated in the second Conference on Clinical Cancer Research, hosted by Friends of Cancer Research and the Engelberg Center for Health Reform at the Brookings Institute.  The 2008 conference identified specific areas of clinical research that could be “de-bureaucracied”.  In 2009, the conference presented the progress made in the past year, and identified next steps.

Following is background and a report on my panel’s discussion regarding centralized review of scans to determine progression free survival in phase 3 trials.

Warning: this meeting delved into highly technical aspects of clinical research, so the following is a little geeky!

Read the rest of this entry »

Comments (0): Add a comment
Page 25 of 33« First...1020...2324252627...30...Last »